key: cord-0008161-s8aen05o
authors: Rimmelzwaan, Guus F; Fouchier, Ron AM; Osterhaus, Albert DME
title: Age distribution of cases caused by different influenza viruses
date: 2013-07-23
journal: Lancet Infect Dis
DOI: 10.1016/s1473-3099(13)70181-6
sha: 492e5272f0bb4bdadfc86b2d6a4002a65b782d98
doc_id: 8161
cord_uid: s8aen05o

nan

As of May 30, 2013, an outbreak 1 of avian infl uenza A H7N9 virus had caused 132 human cases of infl uenza in China, most of which resulted in severe disease and 37 of which were fatal. 2 These H7N9 viruses are avian infl uenza viruses with low pathogenicity. Gene segments are derived from H9N2 viruses of poultry origin and the haemagglutinin and neuraminidase gene segments come from wild-bird origin H7 and N9 viruses, respectively. 1 71% of 131 reported cases have been in individuals older than 50 years, 3 and thus such patients seem more at risk of severe disease and death than are younger individuals. 4 The reasons for this disproportionate age distribution are largely unknown. It has been speculated that older individuals might have higher exposure to infected poultry, which could also be the reason why more men than women are aff ected. 5 However, many patients did not report contact with poultry, the incidence of H7N9 infl uenza virus infections in poultry seems very low, and the incidence of avian infl uenza A H5N1 virus infections was higher in younger than in older individuals within the same population, all of which argue against this possible explanation.

Alternatively, elderly people could be more prone to develop severe disease upon infection with avian infl uenza A H7N9 viruses. Ageing is an important risk factor in viral respiratory tract infections (eg, caused by infl uenza or severe acute respiratory syndrome coronavirus) and is associated with changes in immune function. 6 In elderly people, these infections can cause severe pneumonia triggered by exacerbated innate host responses, which was confi rmed experimentally in aged non-human primates. 7 However, the disease caused by H7N9 viruses resembles that caused by H5N1 viruses, and therefore changes in innate immunity are unlikely to be the only cause of the disproportionate age distribution.

The age distribution of patients infected with H7N9 contrasts with that of the 2009 pandemic infl uenza A H1N1 virus. This virus was of swine origin and its haemagglutinin gene resembled that of human infl uenza A H1N1 viruses that circulated before 1950. 8 Therefore, individuals born before 1957 could have been exposed to these viruses earlier in life and developed antibodies or memory B cells, or both, that cross-reacted with the pandemic A H1N1 viruses. 9,10 The older age group were aff orded some protection against the pandemic strain via the presence of these cross-reactive antibodies, 11 and were therefore spared compared with younger people during the 2009 pandemic and subsequent infl uenza seasons in which the virus continued to circulate.

We postulate that interference of pre-existing antibodies with infection of elderly people by pandemic A H1N1 virus might have had negative eff ects. It might have prevented the induction of recall cross-reactive virus-specifi c T-cell response, which could contribute to heterosubtypic immunity. Rapid and strong CD4 and CD8 T-cell responses were recorded in individuals infected with the pandemic A H1N1 virus, 12 which might have been absent in older patients as a result of protective pre-existing antibodies to pandemic A H1N1 virus, resulting in higher susceptibility to infection with H7N9 virus (fi gure). Similarly, yearly vaccination of highrisk patients against seasonal infl uenza prevented the induction of virus-specifi c CD8 T-cell responses, which would usually be induced by natural infection with seasonal infl uenza viruses 13 and was noted in animal models. 14 A possible explanation is that the presence of cross-reactive antibodies predisposed for more severe disease, a fi nding that, although not previously noted in infl uenza, has been reported for some viral diseases. 15 During the infl uenza pandemic of 1957, which was caused by the H2N2 subtype, individuals who had previously been infected with the H1N1 virus were less likely to be infected with H2N2 infl uenza than were those who had not. 16 The low incidence of severe H5N1 infections in elderly compared with younger people might be related to the presence of cross-protective antibodies to neuraminidase that are induced by seasonal infl uenza A H1N1 viruses. 17 Overall, we postulate that antibodies to pre-1957 infl uenza A H1N1 viruses protected elderly people against pandemic A H1N1 virus infection, but consequently aff ected the development of heterosubtypic immunity and the disease outcome of H7N9 virus infections. The rate and timing of pandemic A H1N1 virus infections might have revealed the diff erences in H7N9 disease outcome, by contrast with historical infections with seasonal infl uenza A H3N2 viruses. This counterproductive imprinting of immunity might increase susceptibility to H7N9 virus infection. For that reason, older individuals should be given priority for vaccination if sustained person-to-person transmission of H7N9 viruses emerges. To obtain a better understanding of the role of imprinting of the adaptive immune system in H7N9 disease severity, prospective cohort studies in which cross-reactive T-cell immunity and virus-specifi c serum antibodies are tested for are imperative before possible wider spread of the virus. Community-acquired pneumonia is a life-threatening disease. An estimated 8% of patients are admitted to intensive care and overall estimated 30 day mortality is 4-11%. 1 Many bacteria and viruses cause community-acquired pneumonia (and can co-infect), and the causative pathogen (or pathogens) cannot be predicatively identifi ed by any clinical, radiological, or biological methods. 2 Accordingly, antibiotic treatment is empirical, and guidelines recommend a combination of a β lactam with a macrolide. 2, 3 Identifi cation of the causative pathogen is usually delayed because clinical specimens are processed in a core laboratory, which is often in a diff erent centre from the patient and the doctor. Culturing, if done, can also take several days.

Human infection with a novel avian-origin infl uenza A (H7N9) virus

Number of confi rmed human cases of avian infl uenza A(H7N9) reported to WHO

MCEIRS

Human infections with avian infl uenza A(H7N9) virus in China: preliminary assessments of the age and sex distribution

Preliminary report: epidemiology of the avian infl uenza A(H7N9) outbreak in China

The role of immunity in susceptibility to respiratory infection in the aging lung

Exacerbated innate host response to SARS-CoV in aged non-human primates

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) infl uenza viruses circulating in humans

Cross-reactive antibody responses to the 2009 pandemic H1N1 infl uenza virus

In vitro and in vivo characterization of new swine-origin H1N1 infl uenza viruses

Immunity to pre-1950 H1N1 infl uenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) infl uenza virus

Characterization of the human CD8(+) T cell response following infection with 2009 pandemic infl uenza H1N1 virus

Annual vaccination against infl uenza virus hampers development of virus-specifi c CD8(+) T cell immunity in children

Annual infl uenza vaccination aff ects the development of heterosubtypic immunity

Vaccine-induced enhancement of viral infections

Prior H1N1 infl uenza infection and susceptibility of Cleveland family study participants during the H2N2 pandemic of 1957: an experiment of nature

Cross-reactive neuraminidase antibodies aff ord partial protection against H5N1 in mice and are present in unexposed humans